These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 11378160

  • 1. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A, Rivet JM, Gobert A, Millan MJ.
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ, Girardon S, Monneyron S, Dekeyne A.
    Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ, Iob L, Péglion JL, Dekeyne A.
    Psychopharmacology (Berl); 2007 Apr 14; 191(3):767-82. PubMed ID: 17047933
    [Abstract] [Full Text] [Related]

  • 4. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 14; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 5. Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.
    Dekeyne A, Iob L, Millan MJ.
    Neuropharmacology; 2003 Apr 14; 44(5):604-15. PubMed ID: 12668046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ, Baker LE.
    Pharmacol Biochem Behav; 1999 Oct 14; 64(2):373-8. PubMed ID: 10515316
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
    Eltayb A, Lindblom S, Oerther S, Ahlenius S.
    Acta Physiol Scand; 2001 Jul 14; 172(3):205-9. PubMed ID: 11472307
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
    Corbin AE, Meltzer LT, Ninteman FW, Wiley JN, Christoffersen CL, Wustrow DJ, Wise LD, Pugsley TA, Heffner TG.
    Neuropharmacology; 2000 Apr 27; 39(7):1211-21. PubMed ID: 10760363
    [Abstract] [Full Text] [Related]

  • 16. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J, Meltzer HY.
    Brain Res; 2000 Mar 10; 858(2):252-63. PubMed ID: 10708676
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL, Alling KL.
    Behav Pharmacol; 2000 Sep 10; 11(6):483-93. PubMed ID: 11103914
    [Abstract] [Full Text] [Related]

  • 18. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
    Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH.
    Biol Psychiatry; 2000 Aug 01; 48(3):229-37. PubMed ID: 10924666
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M, von Euler G.
    Neurochem Int; 2001 Jan 01; 38(1):31-42. PubMed ID: 10913686
    [Abstract] [Full Text] [Related]

  • 20. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 01; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.